NorthWest Biotherapeutics Inc (NWBO)

[Milner1]

Approval in the United States Before Other Countries

Comparing approval to other countries offers another measure of approval efficiency. Although regulatory processes differ widely between FDA and those of regulatory agencies in other countries, 19 of the 22 novel drugs approved in 2016 (86%) were approved in the United States before receiving approval in any other country.
Drugs approved first in the U.S. include: Anthim, Axumin, Cinqair, Epclusa, Eucrisa, Exondys 51, Lartruvo, Netspot, Nuplazid, Ocaliva, Rubraca, Spinraza, Taltz, Tecentriq, Venclexta, Xiidra, Zepatier, Zinbryta, Zinplava


86%

Linda will bk nwbo before us approval!!!! imo